Kimberley E. Honeysett Sells 4,007 Shares of Varex Imaging Co. (NASDAQ:VREX) Stock

Varex Imaging Co. (NASDAQ:VREX - Get Free Report) SVP Kimberley E. Honeysett sold 4,007 shares of the firm's stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total transaction of $51,329.67. Following the transaction, the senior vice president now directly owns 4,002 shares in the company, valued at approximately $51,265.62. The trade was a 50.03 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Varex Imaging Price Performance

Shares of VREX traded down $0.14 during mid-day trading on Tuesday, reaching $12.31. The company had a trading volume of 374,231 shares, compared to its average volume of 527,389. The company's 50-day moving average is $13.26 and its 200-day moving average is $13.44. The company has a debt-to-equity ratio of 1.02, a current ratio of 4.36 and a quick ratio of 2.50. The company has a market capitalization of $507.17 million, a P/E ratio of -10.52 and a beta of 0.56. Varex Imaging Co. has a twelve month low of $10.19 and a twelve month high of $18.30.

Varex Imaging (NASDAQ:VREX - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. On average, equities analysts anticipate that Varex Imaging Co. will post 0.53 EPS for the current year.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms have weighed in on VREX. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a report on Friday, February 7th. Oppenheimer reduced their price target on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a report on Friday, February 7th. Finally, B. Riley reissued a "buy" rating and set a $22.00 target price (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th.

Institutional Trading of Varex Imaging

Several hedge funds have recently modified their holdings of VREX. Aquatic Capital Management LLC bought a new stake in Varex Imaging during the 4th quarter worth approximately $25,000. Quest Partners LLC acquired a new position in Varex Imaging in the third quarter worth $41,000. Quadrant Capital Group LLC grew its holdings in shares of Varex Imaging by 115.4% during the fourth quarter. Quadrant Capital Group LLC now owns 2,837 shares of the company's stock worth $41,000 after purchasing an additional 1,520 shares during the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of Varex Imaging in the fourth quarter valued at $48,000. Finally, KLP Kapitalforvaltning AS bought a new position in shares of Varex Imaging in the fourth quarter valued at about $98,000.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.